Characterization of a human alternatively spliced truncated reduced folate carrier increasing folate accumulation in parental leukemia cells

European Journal of Biochemistry

Volumn 267, Issue 3, 2000, Pages 690-702

  Drori, Stavit ^a   Sprecher, Hannah ^a   Shemer, Gidi ^a   Jansen, Gerrit ^b   Goldman, I David ^c   Assaraf, Yehuda G ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Alternative splicing; Folates; Metabolism; Transporters

Indexed keywords

CARRIER PROTEIN; COMPLEMENTARY DNA; FOLATE CARRIER; FOLIC ACID; FOLINIC ACID; ISOPROTEIN; METHOTREXATE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BIOACCUMULATION; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DRUG TRANSPORT; GENE DELETION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

3' UNTRANSLATED REGIONS; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; CELL DIVISION; DNA PRIMERS; DNA, COMPLEMENTARY; DNA, NEOPLASM; FOLIC ACID; HUMANS; LEUKEMIA; LEUKEMIA L1210; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; METHOTREXATE; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; RNA, NEOPLASM; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033967579     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01049.x     Document Type: Article

References (54)

1. 1. Stokstad, E.L.R. (1990) Historical perspective on key advances in the biochemistry and physiology of folates. In Folic Acid Metabolism in Health and Disease (Picciano, M.F., Stokstad, E.L.R. & Gregory, J.F., eds), pp. 1-21. Wiley-Liss, New York.
2. 2. Jansen, G. (1999) Receptor-and carrier-mediated transport systems for folates and antifolates. In Antifolate Drugs in Cancer Therapy (Jackman, A.L., ed.), pp. 293-321. Humana Press Inc, Totoja, NJ, USA.
3. 3. Goldman, I.D. & Matherly, L.H. (1985) The cellular pharmacology of methotrexate. Pharmacol. Ther. 28, 77-102.
4. 4. Sirotnak, F.M. (1985) Obligate genetic expression in tumor cells of a fetal membrane property mediating 'folate' transport: biological significance and implications for improved therapy of human cancer. Cancer Res. 45, 3992-4000.
5. 5. Goldman, I.D. (1971) The characteristics of the membrane transport of amethopterin and the naturally occurring folates. Ann. NY Acad. Sci. 186, 400-422.
6. 6. Henderson, G.B. & Zevely, E.M. (1981) Anion exchange mechanism for transport of methotrexate in L1210 cells. Biochem. Biophys. Res. Commun. 99, 163-169.
7. 7. Sirotnak, F.M. (1987) Determinants of resistance to antifolates: biochemical phenotypes, their frequency of occurence and circumvention. NCI Monogr. 5, 27-35.
8. 8. Westerhof, G.R., Schornagel, J.H., Kathman, I., Jackman, A.L., Rosowsky, A., Forsch, R.A., Hynes, J.B., Boyle, F.T., Peters, G.J., Pinedo, H.M. & Jansen, G. (1995) Carrier-and receptor-mediated transport of folate antagonists targeting folate dependent enzymes: correlates of molecular structure and biological activity. Mol. Pharmacol. 48, 459-471.
9. 9. Wang, X., Shen, F., Freisheim, J.H., Gentry, L.F. & Ratnam, M. (1992) Differential stereospecificities and affinities of folate receptor isoforms of folate compounds and antifolates. Biochem. Pharmacol. 44, 1898-1901.
10. 10. Antony, A.C. (1992) The biological chemistry of folate receptors. Blood 79, 2807-2820.
11. 11. Brigle, K.E., Spinella, M.J., Westin, E.H. & Goldman, I.D. (1994) Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells. Biochem. Pharmacol. 47, 337-345.
12. 12. Henderson, G.B. & Strauss, B.P. (1990) Characteristics of a novel transport system for folate compounds in wild type and methotrexate-resistant L1210 cells. Cancer Res. 50, 1709-1714.
13. 13. Sierra, E.E. & Goldman, I.D. (1998) Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function. Biochem. Pharmacol. 55, 1505-1512.
14. 14. Kumar, C.K., Moyer, M.P., Dudeja, P.K. & Said, H.M. (1997) A protein-tyrosine kinase-regulated, pH-dependent, carrier-mediated uptake system for folate in human normal colonic epithelial cell line NCM460. J. Biol. Chem. 272, 6226-6231.
15. 15. Assaraf, Y.G., Babani, S. & Goldman, I.D. (1998) Increased activity of a novel low pH folate transporter associated with lipophilic antifolate resistance in Chinese hamster ovary cells. J. Biol. Chem. 273, 8106-8111.
16. 16. Dixon, K.H., Lanpher, B.C., Chiu, J., Kelley, K. & Cowan, K.H. (1994) A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J. Biol. Chem. 269, 17-20.
17. 17. Williams, F.M.R., Murray, R.C., Underhill, T.M. & Flintoff, W.F. (1994) Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake. J. Biol. Chem. 269, 5810-5816.
18. 18. Williams, F.M.R. & Flintoff, W.F. (1994) Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake. J. Biol. Chem. 270, 2987-2992.
19. 19. Prasad, P.D., Ramamoorty, S., Leibach, F.H. & Ganapathy, V. (1995) Molecular cloning of the human placental folate transporter. Biochem. Biophys. Res. Commun. 206, 681-687.
20. 20. Moscow, J.A., Gong, M.K., He, R., Sgagias, M.K., Dixon, K.H., Anzick, S.L., Meltzer, P.S. & Cowan, K.H. (1995) Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res. 55, 3790-3794.
21. 21. Wong, S.C., Proefke, S.A., Bhushan, A. & Mathelry, L.H. (1995) Isolation of human cDNAs that restore methotrexate sensitivity. J. Biol. Chem. 270, 17468-17475.
22. 22. Roy, K., Tolner, B., Chiao, J.H. & Sirotnak, F.M. (1998) A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter within the plasma membrane of tumor cells. J. Biol. Chem. 273, 2526-2531.
23. 23. Matherly, L.H., Angeles, S.M. & Czajkowski, C.A. (1992) Chatacterization of transport-mediated methotrexate resistance in human tumor cells with antibodies to membrane carrier for methotrexate and tetrahydrofolate cofactors. J. Biol. Chem. 267, 23253-23260.
24. 24. Freisheim, J.H., Ratnam, M., McAlinden, T.P., Prasad, K.M.R., Williams, F.E., Westerhof, G.R., Schornagel, J.H. & Jansen, G. (1992) Molecular events in membrane transport of methotrexate in human CCRF-CEM leukemia cells. Adv. Enzyme Regul. 32, 17-31.
25. 25. Sirotnak, F.M., Moccio, D.M. & Yang, C.-H. (1984) A novel class of genetic variants of L1210 cell up-regulated for folate analogue transport inward. J. Biol. Chem. 259, 13139-13144.
26. 26. Yang, C.-H., Sirotnak, F.M. & Mines, L.S. (1988) Further studies on a novel class of genetic variants of the L1210 cell with increased folate analogue transport inward. Transport properties of a new variant, evidence for increased levels of a specific transport protein, and its partial characterization following affinity labeling. J. Biol. Chem. 263, 9703-9709.
27. 27. Jansen, G., Westerhof, G.R., Jarmuszewski, M.J.A., Kathmann, I., Rijksen, G. & Schornagel, J.H. (1990) Methotrexate transport in variant human CCRF-CEM cells with elevated levels of the reduced folate carrier: selective effect on carrier-mediated transport of physiological concentrations of reduced folates. J. Biol. Chem. 265, 18272-18277.
28. 28. Sprecher, H., Jansen, G., Drori, S., Schornagel. J.H., Peters, G.J. & Assaraf, Y.G. (1996) Reduced folate carrier gene amplification and overexpression of altered transcripts in human leukemia CEM-7A cells. Proc. Am. Assoc. Cancer Res. 37, 2601.
29. 29. Shemer, G., Sprecher, H., Drori, S., Pirak, E., Jansen, G. & Assaraf, Y.G. (1998) Characterization of the human reduced folate carrier (RFC1) gene and an alternatively spliced transcript. Proc. Am. Assoc. Cancer Res. 39, 431.
30. 30. Fry, D.W., Yalowich, J.C. & Goldman, I.D. (1982) Rapid formation of poly-gamma-glutamyl derivatives of methotrexate and their associtaion with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro. J. Biol. Chem. 257, 1890-1896.
31. 31. Henderson, G.B., Tsuji, J.M. & Kumar, H.P. (1986) Characterization of the individual transport routes that mediate the influx and efflux of methotrexate in CCRF-CEM human lymphoblastic cells. Cancer Res. 46, 1633-1638.
32. 32. Rosowsky, A., Lazarus, H., Yuan, G.C., Beltz, W.R., Mangini, L., Abelson, H.T., Modest, E.J. & Frei, E. III. (1980) Effects of methotrexate esters and other lipophilic antifolates on methotrexate-resistant human leukemic lymphoblasts. Biochem. Pharmacol. 29, 648-652.
33. 33. Brigle, K.E., Spinella, M.J., Sierra, E.E. & Goldman, I.D. (1995) Characterization of a mutation in the reduced folate carrier in a transport defective L1210 murine leukemia cell line. J. Biol. Chem. 270, 22974-22979.
34. 34. Chomczynski, P. & Sacchi, N. (1987) A single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
35. 35. Maniatis, T., Fritsch, E.F. & Sambrook, J. (1982) Molecular Cloning: a Laboratory Manual, pp. 191-193. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, USA.
36. 36. Sprecher, H., Barr, H.M., Slotky, J.I., Tzukerman, M., Eytan, G.D. & Assaraf, Y.G. (1995) Alteration of mitochondrial gene expression and disruption of respiratory function by the lipophilic antifolate pyrimethamine in mammalian cells. J. Biol. Chem. 270, 20668-20676.
37. 37. Feinberg, A.P. & Vogelstein, B. (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13.
38. 38. Ponte, P., Ng, S.-Y., Engel, J., Gunning, P. & Kedes, L. (1984) Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res. 12, 1687-1706.
39. 39. Shen, D.-W., Fojo, A., Roninson, I.B., Chin, J.E., Soffir, R., Pastan, I. & Gottesman, M.M. (1986) Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdr1 gene. Mol. Cell. Biol. 6, 4039-4044.
40. 40. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
41. 41. Yang-Feng, T.L., Ma, Y.-Y., Liang, R., Prasad, P.D., Leibach, F.H. & Ganapathy, V. (1995) Assignment of the human folate transporter gene to chromosome 21q22.3 by somatic cell hybrid analysis and in situ hybridization. Biochem. Biophys. Res. Commun. 210, 874-879.
42. 42. Lapenta, V., Sossi, V., Gosset, P., Vassettes, C., Vitali, T., Rabatel, N., Rabatel, N., Tassone, F., Blouin, J.L., Scott, H.S., Antonarakis, S.E., Creau, N. & Brahe, C. (1998) Construction of a 2.5-Mb integrated physical and gene map of distal 21q22.3. Genomics 49, 1-13.
43. 43. Jansen, G., Mauritz, R., Drori, S., Sprecher, H., Kathmann, I., Bunni, M., Priest, D.G., Noordhuis, P., Schornagel, J.H., Pinedo, H.M., Peters, G.J. & Assaraf, Y.G. (1998) A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. J. Biol. Chem. 273, 30189-30198.
44. 44. Ferguson, P.L. & Flintoff, W.F. (1999) Topological and functional analysis of the human reduced folate carrier by hemagglutinin epitope insertion. J. Biol. Chem. 274, 16269-12278.
45. 45. Schimke, R.T. (1984) Gene amplification in cultured animal cells. Cell 37, 705-713.
46. 46. Schimke, R.T. (1988) Gene amplification in cultured cells. J. Biol. Chem. 263, 5989-5992.
47. 47. Chabot, B. (1996) Directing alternative splicing: cast and scenarios. Trends Genet. 12, 472-478.
48. 48. Assaraf, Y.G. & Goldman, I.D. (1997) Loss of folic acid exporter function with markedly augmented folate accumulation in lipophilic antifolate-resistant mammalian cells. J. Biol. Chem. 272, 17460-17466.
49. 49. Kool, M., de Hoos, M., Scheffer, G.L., Scheper, R.J., van Eijk, M.J., Juin, J.A., Baas, F. & Borst, P. (1997) Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57, 3527-3547.
50. 50. Masuda, M., Fizuka, Y., Yamazaki, M., Nishigaki, R., Kato, Y., Ni'inuma, K., Suzuki, H. & Sugiyama, Y. (1997) Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. Cancer Res. 57, 3506-3510.
51. 51. Hooijberg, J.H., Broxterman, H.J., Kool, M., Assaraf, Y.G., Peters, F.J., Noordhuis, P., Scheper, R., Borst, P., Pinedo, H.M. & Jansen, G. (1999) Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res. 59, 2532-2535.
52. 1 is a potent inhibitor of membrane transport of folates mediated by the reduced folate carrier and ATP-driven exporters. Biochem. Pharmacol. 58, 1321-1327.
53. 53. Poruchynsky, M.S. & Ling, V. (1994) Detection of oligomeric and monomeric forms of P-glycoprotein in multidrug resistant cells. Biochemistry 33, 4163-4174.
54. 54. Haugeto, O., Ullensvang, K., Levy, L.M., Chaudhry, F.A., Honore, T., Nielsen, M., Lehre, K.P. & Danbolt, N.C. (1996) Brain glutamate transporter proteins form homomultimers. J. Biol. Chem. 271, 27715-27722.